HI - Hillenbrand Schedules Fourth Quarter 2022 Earnings Call for November 17 2022
PR Newswire
BATESVILLE, Ind. , Nov. 2, 2022 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) will hold a conference call and simultaneous webcast Thursday, November 17, 2022 , at 8:00 a.m. ET . They will discuss the results for the fourth quarter and full fiscal year 2022, which ended September 30, 2022 . The live webcast, including a slide presentation, will be available at http://ir.hillenbrand.com under the "News & Events" tab and will be archived on the company's investor relations website through Friday, December 16, 2022 .
To access the conference call, listeners in the United States and Canada may dial +1 (877) 407-8012, and international callers may dial +1 (412) 902-1013. Please use conference call ID number 13733078. A replay of the call will be available until midnight ET , Thursday, December 1, 2022 , by dialing +1 (877) 660-6853 toll free in the United States and Canada or +1 (201) 612-7415 internationally and using the conference ID number 13733078.
Hillenbrand will issue a press release reporting its results after the market closes on Wednesday, November 16, 2022 . The full text of the release and financials will be available at http://ir.hillenbrand.com .
Hillenbrand (NYSE: HI) is a global industrial company operating in over 40 countries with over 10,000 associates serving a wide variety of industries around the world. Guided by our Purpose — Shape What Matters For Tomorrow™ — we pursue excellence, collaboration, and innovation to consistently shape solutions that best serve our associates, customers, communities, and other stakeholders. Hillenbrand's portfolio includes brands such as Coperion, Milacron Injection Molding & Extrusion, and Mold-Masters, in addition to Batesville . To learn more, visit: www.Hillenbrand.com .
SOURCE Hillenbrand, Inc.
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by PR Newswire via Quote Media. Read our full disclaimer.